HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia Zimmer Selected Research

Congenital Diaphragmatic Hernias

2/2021Pbx1, Meis1, and Runx1 Expression Is Decreased in the Diaphragmatic and Pulmonary Mesenchyme of Rats with Nitrofen-Induced Congenital Diaphragmatic Hernia.
2/2019Ephrin-B1, -B2, and -B4 Expression is Decreased in Developing Diaphragms and Lungs of Fetal Rats with Nitrofen-Induced Congenital Diaphragmatic Hernia.
2/2019Expression of Nitric Oxide Synthase Interacting Protein (NOSIP) is Decreased in the Pulmonary Vasculature of Nitrofen-Induced Congenital Diaphragmatic Hernia.
1/2019Expression of dispatched RND transporter family member 1 is decreased in the diaphragmatic and pulmonary mesenchyme of nitrofen-induced congenital diaphragmatic hernia.
3/2018Gata-6 expression is decreased in diaphragmatic and pulmonary mesenchyme of fetal rats with nitrofen-induced congenital diaphragmatic hernia.
2/2018Downregulated Elastin Microfibril Interfacer 1 Expression in the Pulmonary Vasculature of Experimental Congenital Diaphragmatic Hernia.
2/2018Increased CaSR and TRPC6 pulmonary vascular expression in the nitrofen-induced model of congenital diaphragmatic hernia.
1/2018Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia.
6/2017Down-regulation of N-deacetylase-N-sulfotransferase-1 signaling in the developing diaphragmatic vasculature of nitrofen-induced congenital diaphragmatic hernia.
5/2017Follistatin-like 1 expression is decreased in the alveolar epithelium of hypoplastic rat lungs with nitrofen-induced congenital diaphragmatic hernia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia Zimmer Research Topics

Disease

21Congenital Diaphragmatic Hernias
02/2021 - 02/2016
5Vascular Remodeling
02/2018 - 02/2016
2Diaphragmatic Hernia
02/2018 - 02/2016
1Critical Illness (Critically Ill)
02/2021
1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
02/2021
1Fistula
02/2019
1Esophageal Atresia
12/2018
1Pathologic Constriction (Stenosis)
12/2018
1Pulmonary Hypertension
02/2017
1Hypertrophy
11/2015
1Seasonal Allergic Rhinitis (Hay Fever)
02/2015
1Inborn Genetic Diseases (Disease, Hereditary)
01/2012
1Type B1 Brachydactyly
01/2012
1Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
01/2012
1Rheumatoid Arthritis
11/2003

Drug/Important Bio-Agent (IBA)

21nitrofenIBA
02/2021 - 02/2016
2Proteins (Proteins, Gene)FDA Link
02/2019 - 02/2016
1Anti-Bacterial Agents (Antibiotics)IBA
02/2021
1Pharmaceutical PreparationsIBA
02/2021
1Cephalosporins (Cephalosporin Antibiotics)IBA
02/2021
1CefiderocolIBA
02/2021
1Core Binding Factor Alpha 2 SubunitIBA
02/2021
1Nitric Oxide Synthase (NO Synthase)IBA
02/2019
1Ephrin-B1 (Ephrin B1)IBA
02/2019
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2018
1CausticsIBA
12/2018
1TRPC6 Cation ChannelIBA
02/2018
1ElastinIBA
02/2018
1elastin microfibril interface located protein (emilin)IBA
02/2018
1ChemokinesIBA
01/2018
1Rosiglitazone (Avandia)FDA Link
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2018
1FollistatinIBA
05/2017
1CalcineurinIBA
02/2017
1Transcription Factors (Transcription Factor)IBA
02/2017
1Fibrillin-1IBA
02/2017
1EndoglinIBA
02/2017
1DesminIBA
12/2016
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2016
1Stem Cell FactorIBA
05/2016
1Activin Receptors (Activin Receptor)IBA
02/2016
1Antihypertensive Agents (Antihypertensives)IBA
11/2015
1AllergensIBA
02/2015
1Amino AcidsFDA Link
01/2012
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2012
1HLA-DRB1*04 antigenIBA
11/2003

Therapy/Procedure

3Therapeutics
02/2021 - 02/2015
1Ligation
02/2019